In a pandemic milestone, the NIH ends guidance on COVID treatment
The National Institutes of Health is sunsetting its influential COVID-19 treatment guidelines, used by millions of doctors to guide care during the pandemic.
remdesivir
Why remdesivir, a highly effective treatment, is a last resort for providers
The antiviral infusion was just revived as an early treatment for COVID patients. But the drug is relatively expensive and hard to administer, relegating it what some are calling "stopgap" status.
WHO Trial Finds Remdesivir Has 'No Meaningful Effect' In COVID-19 Patients
The medicine is one of the few to win regulatory approval as a treatment for the disease, but has fallen out of favor with the health authority.
Eli Lilly Ends Coronavirus Antibody Treatment Trial, Other Studies Go On
The trial studied the efficacy of bamlanivimab and remdesivir on hospitalized COVID-19 patients - the same therapies given to President Trump. But researchers say people showed no marked improvement.
Ironic Twist: In Spring Trump Halted Research Key To COVID-19 Drug He's Now Taken
The drug remdesivir emerged in part because researchers had previously tested it in China through a project whose grant was abruptly ended by the National Institutes of Health.
Trump Is Taking Remdesivir. Here's How It Works To Control The Coronavirus
President Trump is on day two of a planned 5-day course of remdesivir. The medication, approved for treating COVID-19, works by making it harder for the coronavirus to replicate within the body.
Advances In ICU Care Are Saving More Patients Who Have COVID-19
One thing that has improved a lot over the course of the pandemic is treatment of seriously ill COVID-19 patients in intensive care units. Here's one man's success story.
How Feds Decide On Remdesivir Shipments To States Remains Mysterious
The federal government is in charge of distributing one of the few treatment options for COVID-19: the antiviral drug remdesivir. But how are decisions made about which states need it most?
Remdesivir Priced At More Than $3,100 For A Course Of Treatment
An experimental COVID-19 medicine that has been shown to shorten the time people with severe illness have to stay in the hospital finally has a price tag that's lower than some analysts expected.
Five Coronavirus Treatments In Development
While only remdesivir has been scientifically shown to help treat COVID-19, it is not a particularly effective drug. More drugs like it and fundamentally different ones are in the pipeline.